FGF401
Lintlha tsa Sehlahisoa
Li-tag tsa Sehlahisoa
| Boholo ba Pakete | Ho fumaneha | Theko (USD) |
| 10mg | E teng thepeng e teng ka lebenkeleng | 300 |
| 50mg | E teng thepeng e teng ka lebenkeleng | 500 |
| 100mg | E teng thepeng e teng ka lebenkeleng | 800 |
| Boholo bo Eketsehileng | Fumana Litlhaloso | Fumana Litlhaloso |
Lebitso la lik'hemik'hale:
N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4 -dihydro-1,8-naphthyridine-1 (2H) -carboxamide
SMILES Khouto:
CN1CC(N(N(CC2=CC(CCCN3C(NC4=CC(NCCOC))=C(C#N)C=N4)=O)=C3N=C2C=O)CC1)=O
Khoutu ea InChi:
InChI=1S/C25H30N8O4/c1-31-7-8-32(23(35)15-31)14-18-10-17-4-3-6-33(24(17)29-21(18) 16-34)25(36)30-22-11-20(27-5-9-37-2)19(12-26)13-28-22/h10-11,13,16H,3-9, 14-15H2,1-2H3,(H2,27,28,30,36)
InChi Key:
BHKDKKZMPODMIQ-UHFFFAOYSA-N
Keyword:
FGF401, FGF-401, FGF 401, 1708971-55-4
Sollubility:E qhibiliha ka DMSO
Polokelo:0 - 4 ° C bakeng sa nako e khutšoanyane (matsatsi ho isa libeke), kapa -20 ° C bakeng sa nako e telele (likhoeli).
Tlhaloso:
FGF-401 ke inhibitor ea FGFR4 e ntšitsoeng ho patent WO2015059668A1, mohlala oa motsoako 83; e na le IC50 ea 1.9 nM.
Sepheo: FGFR4
